Option Care Health

Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Option Care Health surpasses Q4 expectations, eyes growth opportunities

Option Care Health's Q4 performance reflects growth and resilience amidst inflation challenges. The company's financial strength, focus on efficiency, and strategic initiatives position it well for future expansion and value creation.

Option Care Health reports robust Q2 earnings amidst strategic growth focus

Option Care Health's Q2 2023 earnings call highlighted strong financial performance, with revenue growth and adjusted EBITDA exceeding expectations. The company's strategic initiatives focus on innovation, operational efficiency, and patient care excellence.
While facing challenges like reimbursement issues and cost pressures, Option Care Health remains optimistic about sustainable growth and shareholder value. Investments in capabilities and network expansion position the company for future opportunities.
Analysts' inquiries into revenue growth composition, cost challenges, and future outlooks were addressed with a focus on operational excellence and sustainable growth. Option Care Health's performance reflects a balance of financial strength and strategic vision.

Option Care Health excels in Q3 performance and eyes M&A for growth

Option Care Health's Q3 earnings call highlighted strong financial performance, successful collaboration, and strategic focus on M&A for shareholder value. Challenges include revenue pressure in Q4 and sustainability of procurement benefits for 2024 projections.

Option Care Health exceeds revenue expectations, eyes strategic growth

Option Care Health's strong financial performance in 2023 positions the company for continued growth.
Strategic initiatives, operational efficiencies, and engagement with payers highlight the company's resilience.
Navigating market dynamics, optimizing procurement benefits, and strategic growth remain key focus areas for 2024.

Option Care Health reports resilient Q1 performance and growth opportunities

Option Care Health's Q1 2024 performance showcased revenue growth, strong patient satisfaction, and resilience in maintaining financial strength.
Despite challenges from the cybersecurity incident and supply chain disruptions, the company remains focused on growth and operational improvements.
Opportunities lie in expanding services, portfolio diversification, and adapting to evolving patient needs for continued success in 2024.
With disciplined SG&A management and a commitment to patient care, Option Care Health is poised for growth and service expansion.

Option Care Health excels in Q2, boosts revenue outlook

Option Care Health's Q2 performance reflects resilience and strategic focus, driving revenue growth and operational efficiency.
Despite challenges, the company's strengths in financial management and capital deployment position it well for future opportunities.
With increased revenue expectations and a strong cash flow rebound, Option Care Health is poised for sustained growth and value creation.

Option Care Health reports resilient Q3 performance amid operational challenges

Option Care Health's Q3 2024 performance showcased growth and financial resilience amidst operational challenges.
The company's strategic focus on managing costs and pursuing growth initiatives positions it well to address upcoming gross margin pressures.
Despite facing headwinds, Option Care Health remains optimistic about its revenue outlook for the full year 2024 and beyond.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Option Care (OPCH) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.19 per share a year ago.

Option Care (OPCH) Q2 Earnings and Revenues Surpass Estimates

BANNOCKBURN, Ill., July 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2023.

Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2023

U.S. Physical Therapy

Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Option Care (OPCH) or U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their buck right now?

OPCH or USPH: Which Is the Better Value Stock Right Now?

Option Care (OPCH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Here's Why Momentum in Option Care (OPCH) Should Keep going

BANNOCKBURN, Ill., July 06, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2023 on Thursday, July 27, 2023 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Option Care Health to Announce Second Quarter 2023 Financial Results and Host Conference Call

Option Care (OPCH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Option Care (OPCH) Moves 5.2% Higher: Will This Strength Last?

Amedisys

UnitedHealth Group

Amedisys Inc. AMED, -0.15% disclosed Monday that it has agreed to merge with UnitedHealth Group Inc. UNH, -0.43%, and terminated its merger with Option Care Health Inc. OPCH, +1.47% agreed on in early-May. Under terms of deal with UnitedHealth, each Amedisys share will be converted into the right to receive $101 in cash, which represents as 10.7% premium to Friday's closing price of $91.21.

Amedisys agrees to merge with UnitedHealth, and terminates deal with Option Care Health

Highlights Strength of Platform and Track Record of Execution and Value Creation BANNOCKBURN, Ill. , June 26, 2023 /PRNewswire/ -- Option Care Health, Inc. ("Option Care Health" or the "Company") (Nasdaq: OPCH) today announced that it has terminated its previously announced agreement to combine with Amedisys, Inc. ("Amedisys").

Option Care Health Confirms Termination of Merger Agreement with Amedisys

Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Option Care (OPCH) Surges 6.3%: Is This an Indication of Further Gains?

Amedisys Inc. AMED, +3.64% disclosed Monday that it had received an unsolicited cash buyout bid for $100 a share from Optum, which the at-home healthcare services company believes could be considered “superior” to the buyout deal already agreed on with Option Care Health Inc. OPCH, +2.99% in early May. Amedisys shares were still inactive in premarket trading while Option Care's stock rallied 4.7%.

Amedisys received unsolicited buyout bid from Optum that could be ‘superior' to deal with Option Care Health

Issues Statement in Light of Amedisys' Disclosure of Unsolicited Proposal from Optum BANNOCKBURN, Ill. , June 5, 2023 /PRNewswire/ -- Option Care Health, Inc. ("Option Care Health") (Nasdaq: OPCH) today filed with the U.S. Securities and Exchange Commission a registration statement on Form S-4 containing a joint proxy statement/prospectus in connection with its proposed merger with Amedisys, Inc. ("Amedisys").

Option Care Health Reiterates Value Creation Opportunity of its Previously Announced Definitive Merger Agreement with Amedisys

Amedisys Board Determines Optum Proposal Could Reasonably be Expected to Result in a Superior Proposal

Amedisys Announces Receipt of Unsolicited Proposal From Optum

Company to Deliver to Patients FDA-Approved Topical Treatment for Dystrophic Epidermolysis Bullosa (DEB) Announces Collaboration with Amedisys to Administer Treatment in the Home BANNOCKBURN, Ill., May 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH) today announced that it was selected by Krystal Biotech, Inc. (“Krystal Biotech”) (Nasdaq: KRYS) as part of a limited distribution specialty pharmacy network for VYJUVEK™.

Option Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK™

BANNOCKBURN, Ill., May 05, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, will present at the BofA Securities Health Care Conference on Tuesday, May 9, 2023 in Las Vegas. John Rademacher, Chief Executive Officer, and Mike Shapiro, Chief Financial Officer, are scheduled to present at 11:20am PT.

Option Care Health to Present at the BofA Securities Health Care Conference

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Amedisys, Inc. (NasdaqGS: AMED) to Option Care Health, Inc. ("Option Care") (NasdaqGS: OPCH). Under the terms of the proposed transaction, shareholders of Amedisys will receive 3.0213 shares of Option Care for each share of Amedisys that they own. KSF is seeking to determine whether this consideration and the.

AMEDISYS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amedisys, Inc. - AMED

NEW YORK , May 4, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Amedisys, Inc. (NASDAQ: AMED) and its board of directors concerning the proposed merger of the company with Option Care Health, Inc. (NASDAQ: OPCH). Stockholders will receive 3.0213 shares of Option Care Health common stock for each share of Amedisys stock that they hold.

ALERT: Rowley Law PLLC is Investigating Proposed Merger of Amedisys, Inc.

Option Care (OPCH) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.17 per share a year ago.

Option Care (OPCH) Q1 Earnings and Revenues Top Estimates

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Option Care Health, Inc. (NASDAQ: OPCH) and Amedisys, Inc. is fair to Option Care shareholders. Upon completion of the proposed transaction, Option Care shareholders will own approximately 64.5% of the combined company. Halper Sadeh encourages Option Care shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 7.

OPCH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Option Care Health, Inc. Is Fair to Shareholders

BANNOCKBURN, Ill. , May 3, 2023 /PRNewswire/ -- Option Care Health, Inc. (the "Company" or "Option Care Health") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2023.

OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2023

All-Stock Transaction Combines Highly Complementary Businesses Unlocking Significant Benefits for Patients, Providers, Payers, and Care Teams Increases Access to High Quality Care for Communities Across the U.S. through a Unique National Clinical Platform Comprehensive Capabilities Across Alternate Site Care Spectrum Position Combined Company to Move Deeper into Value-Based Care Highly Attractive Combined Financial Profile Which Generated $6.2 Billion in Revenues and $622 Million in Adjusted EBITDA on a Combined Basis for Full Year 2022 Creates Stockholder Value Including Through Anticipated Annual Run-Rate Revenue and Cost Synergies of Approximately $75 Million by Year Three Following Close Companies to Host Joint Conference Call and Webcast at 5:30 p.m. ET Today, May 3, 2023, to Discuss Transaction BANNOCKBURN, Ill.

Option Care Health and Amedisys to Combine Creating a Leading, Independent Platform for Home and Alternate Site Care

BANNOCKBURN, Ill., April 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH) announces the formation of a nationwide home infusion nursing network and clinical platform that will operate as Naven Health, Inc. (“Naven Health”), focused on delivering specialized, truly exceptional infusion care. Naven Health employs over 1,500 nurses across the country with the ability to provide care in all 50 states.

Introducing Naven Health, a Leader in Nationwide Infusion Nursing

Option Care (OPCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Option Care (OPCH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

BANNOCKBURN, Ill., April 18, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2023 on Thursday, May 4, 2023 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Option Care Health to Announce First Quarter 2023 Financial Results and Host Conference Call

Option Care Health, Inc. has continued seeing the increased top and bottom-line growth, creating a good bull case for investors. The company is part of a steadily growing market, with a CAGR of 8.1% until 2028.

Option Care Health: A Good Bet

Double-digit growth in core business segments, coupled with strong FCF conversion. Profitability remains strong, a good springboard for its growth initiatives for FY23'.

News for Option Care Health Stock (OPCH)